147 related articles for article (PubMed ID: 22028347)
1. Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer.
Loibl S; Gerber B
JAMA; 2011 Oct; 306(16):1760; author reply 1760-1. PubMed ID: 22028347
[No Abstract] [Full Text] [Related]
2. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
[TBL] [Abstract][Full Text] [Related]
3. Reducing the long-term effects of chemotherapy in young women with early-stage breast cancer.
Rugo HS; Rosen MP
JAMA; 2011 Jul; 306(3):312-4. PubMed ID: 21771995
[No Abstract] [Full Text] [Related]
4. Gonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma.
Falorio S; Angrilli F; Fioritoni G
Leuk Lymphoma; 2008 Jun; 49(6):1087-93. PubMed ID: 18452079
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.
Demeestere I; Brice P; Peccatori FA; Kentos A; Gaillard I; Zachee P; Casasnovas RO; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
J Clin Oncol; 2013 Mar; 31(7):903-9. PubMed ID: 23129737
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
Lambertini M; Boni L; Michelotti A; Gamucci T; Scotto T; Gori S; Giordano M; Garrone O; Levaggi A; Poggio F; Giraudi S; Bighin C; Vecchio C; Sertoli MR; Pronzato P; Del Mastro L;
JAMA; 2015 Dec 22-29; 314(24):2632-40. PubMed ID: 26720025
[TBL] [Abstract][Full Text] [Related]
8. Reply to Z. Blumenfeld et al.
Demeestere I; Brice P; Peccatori FA; Kentos A; Gaillard I; Zachee P; Casasnovas O; Van Den Neste E; Dechene J; De Maertelaer V; Bron D; Englert Y
J Clin Oncol; 2013 Oct; 31(29):3722-3. PubMed ID: 24002513
[No Abstract] [Full Text] [Related]
9. GnRH agonist for the prevention of chemotherapy-induced ovarian failure in lymphoma.
Blumenfeld Z; Dann E
J Clin Oncol; 2013 Oct; 31(29):3721. PubMed ID: 24002509
[No Abstract] [Full Text] [Related]
10. Triptorelin for the treatment of endometriosis.
Leone Roberti Maggiore U; Scala C; Remorgida V; Venturini PL; Del Deo F; Torella M; Colacurci N; Salvatore S; Ferrari S; Papaleo E; Candiani M; Ferrero S
Expert Opin Pharmacother; 2014 Jun; 15(8):1153-79. PubMed ID: 24832495
[TBL] [Abstract][Full Text] [Related]
11. Menstrual cycle pattern during the first gynaecological years in girls with precocious puberty following gonadotropin-releasing hormone analogue treatment.
Arrigo T; De Luca F; Antoniazzi F; Galluzzi F; Iughetti L; Pasquino AM; Salerno MC; Marseglia L; Crisafulli G
Eur J Pediatr; 2007 Jan; 166(1):73-4. PubMed ID: 16906400
[No Abstract] [Full Text] [Related]
12. The risk of menopausal symptoms in premenopausal breast cancer patients and current pharmacological prevention strategies.
Lei YY; Yeo W
Expert Opin Drug Saf; 2021 Oct; 20(10):1163-1175. PubMed ID: 33951990
[No Abstract] [Full Text] [Related]
13. Reproductive and hormonal sequelae of chemotherapy in women. Premature menopause and impaired fertility can result, effects that are especially disturbing to young women.
Knobf MT
Am J Nurs; 2006 Mar; 106(3 Suppl):60-5. PubMed ID: 16481857
[No Abstract] [Full Text] [Related]
14. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study.
Giles J; Requena A; García-Velasco JA; Pacheco A; Pellicer J; Pellicer A
Fertil Steril; 2009 Apr; 91(4 Suppl):1366-9. PubMed ID: 18692821
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus.
Brunner HI; Silva CA; Reiff A; Higgins GC; Imundo L; Williams CB; Wallace CA; Aikawa NE; Nelson S; Klein-Gitelman MS; Rose SR
Arthritis Rheumatol; 2015 May; 67(5):1377-85. PubMed ID: 25676588
[TBL] [Abstract][Full Text] [Related]
16. Impact of breast cancer treatment on fertility.
de la Haba-Rodríguez J; Calderay M
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():59-63. PubMed ID: 20711656
[No Abstract] [Full Text] [Related]
17. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials.
Yang B; Shi W; Yang J; Liu H; Zhao H; Li X; Jiao S
Breast; 2013 Apr; 22(2):150-157. PubMed ID: 23298851
[TBL] [Abstract][Full Text] [Related]
18. Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study.
Orefice V; Ceccarelli F; Perrone G; Perricone C; Galoppi P; Pacucci VA; Spinelli FR; Alessandri C; Brunelli R; Conti F
Isr Med Assoc J; 2020 Jun; 22(6):343-347. PubMed ID: 32558438
[TBL] [Abstract][Full Text] [Related]
19. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
Orvieto R; Meltcer S; Homburg R; Nahum R; Rabinson J; Ashkenazi J
Fertil Steril; 2009 Apr; 91(4 Suppl):1466-8. PubMed ID: 18774558
[TBL] [Abstract][Full Text] [Related]
20. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
Kishk EA; Mohammed Ali MH
Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
